TOKYO: Tokyo-based Medident has signed an agreement with Saudi Arabia institutions to link Japan’s medical digital transformation strategy with the Kingdom’s Vision 2030 plan.

The pact was inked at the Japan-Saudi EXPO Investment Forum, the company announced on Sept. 24.

The agreement covers areas including artificial intelligence diagnostics, surgical training, medical device development, and healthcare-education platforms.

Medident also plans to speed up clinical and educational adoption of its 3D Clone Model, a training tool that combines virtual reality with tactile simulation based on various types of medical scans.

“Our initiatives are gaining recognition both academically and at the policy level,” Medident CEO Daisuke Tomita said.